BRKR (Life Sciences Tools & Services) Stock Valuation & Fair Value Significantly overvalued
BRKR (Life Sciences Tools & Services) trades at a blended P/E of 32.2, about 16% above its historical normal valuation, with a forward growth estimate of 15.7% and a PEG of 2.05. Analysts' one-year estimates have been hit 55% of the time.
Valuation flags
- No notable valuation flags.
Frequently asked questions
Is BRKR overvalued?
At a blended P/E of 32.2 versus its historical normal P/E of 27.8, BRKR trades about 16% above its typical valuation, with a PEG of 2.05 on 15.7% forward growth. tickerseer currently rates it significantly overvalued.
What is BRKR's fair value and PEG?
BRKR trades at a blended P/E of 32.2 against a historical normal P/E of 27.8, a PEG of 2.05, and a forward growth estimate of 15.7%.
Has tickerseer's rating of BRKR changed?
tickerseer's rating has been significantly overvalued since 2026-07-31.
Industry: Life Sciences Tools & Services. Create a free account to see the full analysis: the SeerAI score, its five quality sub-scores, valuation history, and the AI research note. Options setups and metric history are part of the paid plans.
Get the free weekly earnings preview
One email each Monday with the week's named earnings setups, the reasoning, and what settled last week. Strikes and sizing stay in the paid plan.
It's free, and you can unsubscribe any time. Educational content, not investment advice.